Meram Tıp Fakültesi

PROF.DR. MEHMET ARTAÇ

NECMETTİN ERBAKAN ÜNİVERSİTESİ
Meram Tıp Fakültesi
Dahili Tıp Bilimleri Bölümü
İç Hastalıkları Anabilim Dalı

E-posta : maytac@erbakan.edu.tr
Makaleler
1. Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study
ARAZ MURAT,KARAAĞAÇ MUSTAFA,KORKMAZ LEVENT,KORAL LOKMAN,İNCİ FATİH,BEYPINAR İSMAİL,UYSAL MÜKREMİN,ARTAÇ MEHMET
Uluslararası
Hakemli
2019
2. The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study
BEYPINAR İSMAİL,DEMİR HACER,SAKİN ABDULLAH,YAPAR TAŞKÖYLÜ BURCU,ŞAKALAR TEOMAN,ERGÜN YAKUP,KORKMAZ MUSTAFA,ATEŞ ÖZTÜRK,EREN TÜLAY,TURHAL SERDAR,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
3. Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study
ÇİÇİN İRFAN,ÇİLTAŞ AYDIN,KILIÇKAP SAADETTİN,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,UNCU DOĞAN,ARTAÇ MEHMET,YEŞİL ÇINKIR HAVVA,IŞIKDOĞAN ABDURRAHMAN,DANE FAYSAL,ALİUSTAOĞLU MEHMET,TÜRK HACI MEHMET,ELKIRAN EMİN TAMER,ÇUBUKÇU ERDEM,EKENEL MELTEM,ÖZDEMİR FEYYAZ,GÖKYER ALİ,ÖZTOP İLHAN,ALACACIOĞLU AHMET,ÖZTÜRK HÜSEYİN,AVER BİRKAN,ÖZKAN METİN
Uluslararası
Hakemli
2020
4. The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial
ARSLAN SELDA,ZORBA BAHÇELİ PINAR,İLİK YETER,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
5. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences
TURAL DENİZ,ÖLMEZ ÖMER FATİH,SÜMBÜL AHMET TANER,ARTAÇ MEHMET,ÖZHAN NAİL,Akar Emre,ÇAKAR BURCU,Köstek Osman,EKENEL MELTEM,ERMAN MUSTAFA,COŞKUN HASAN ŞENOL,SELÇUKBİRİCİK FATİH,KESKİN ÖZGE,Türköz Fatma Paksoy,ORUÇ KEREM,Bayram Selami,Yılmaz Uğur,BİLGETEKİN İREM,Yıldız Birol,ŞENDUR MEHMET ALİ NAHİT,PAKSOY NAİL,DİRİCAN AHMET,Erdem Dilek,SELAM MELTEM,TANRIVERDİ ÖZGÜR,PAYDAŞ SEMRA,URAKÇI ZUHAT,ATAĞ ELİF,GÜNCAN SABRİ,ÜRÜN YÜKSEL,ALKAN ALİ,KAYA ALİ OSMAN,Özyükseler Deniz Tataroğlu,Taşkaynatan Halil,Yıldırım Mustafa,Sönmez Müge,BAŞOĞLU TUĞBA,Gündüz Şeyda,KILIÇKAP SAADETTİN
Uluslararası
Hakemli
2020
6. Irinotecan and Ifosfamide Combination is an Effective and Safe Option in Patients With Refractory Small Cell Lung Cancer: A Retrospective Cross-Sectional Study
KARAAĞAÇ MUSTAFA,ARTAÇ MEHMET,SEZGİN GÖKSU SEMA,KARAKURT ERYILMAZ MELEK,COŞKUN HASAN ŞENOL,BOZCUK HAKAN
Uluslararası
Hakemli
2020
7. The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer
KARPUZ TUBA,ARAZ MURAT,KORKMAZ LEVENT,KILINÇ İBRAHİM,FINDIK SIDDIKA,KARAAĞAÇ MUSTAFA,KARAKURT ERYILMAZ MELEK,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
8. Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer
Bozcuk Hakan,ARTAÇ MEHMET,MUTLU HASAN,SEVER ÖZLEM NURAY,Yıldırım Mustafa
Uluslararası
Hakemli
9. Checkpoint inhibitors in advanced nonsmall-cell lung cancer a Bayesian network meta-analysis
Bozcuk Hakan,Yıldırım Mustafa,SEVER ÖZLEM NURAY,MUTLU HASAN,ARTAÇ MEHMET
Uluslararası
Hakemli
10. Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
BENEKLİ MUSTAFA,GÜMÜŞ MAHMUT,ÖZKAN METİN,DANE FAYSAL,ELKIRAN EMİN TAMER,cicin İrfan,sevinç alper,aliustaoglu Ali,IŞIKDOĞAN ABDURRAHMAN,MEYDAN NEZİH,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZYILKAN ÖZGÜR,ARTAÇ MEHMET,Kılıckap Saadettin
Uluslararası
Hakemli
2020
11. The Real-Life Outcome of Pazopanib in Patients With Advanced Soft Tissue Sarcoma: A Retrospective Cross-Sectional Study of a Turkish Cohort
KARAAĞAÇ MUSTAFA,SEZGİN YASİN,KARAKURT ERYILMAZ MELEK,ARAZ MURAT,KAPLAN MUHAMMET ALİ,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
12. Third-line Treatment is Associated With Prolonged Survival in Patients With Extensive-stage Small Cell Lung Cancer: A Single Center Experience
KARAAĞAÇ MUSTAFA,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
13. Single Center Real Life Experience with Regorafenib in Patients with Metastatic Colorectal Cancer
KARAKURT ERYILMAZ MELEK,KARAAĞAÇ MUSTAFA,ARAZ MURAT,YALÇIN MÜSRİ FATMA,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
14. Small bowel wall edema induced by regorafenib is associated with regorafenib intolerance and shorter survival in patients with metastatic colorectal cancer: A retrospective study
KARAKURT ERYILMAZ MELEK,KERİMOĞLU ÜLKÜ,KARAAĞAÇ MUSTAFA,YALÇIN MÜSRİ FATMA,ARAZ MURAT,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
15. Pemetrexed-induced Sweet Syndrome: First Case Report in the Medical Literature
KORKMAZ MUSTAFA,KARAKURT ERYILMAZ MELEK,KARAAĞAÇ MUSTAFA,DEMİRKIRAN AYKUT,ARAZ MURAT,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
16. The Concomitant Use Of Proton Pump Inhibitors And Pazopanib In Patients With Soft-Tissue Sarcoma: Is It Really To Be Avoided?
KARAAĞAÇ MUSTAFA,SEZGİN YASİN,ARAZ MURAT,KARAKURT ERYILMAZ MELEK,KAPLAN MUHAMMET ALİ,ARTAÇ MEHMET
Uluslararası
Hakemli
2020
17. ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer
KARAAĞAÇ MUSTAFA,ARTAÇ MEHMET,GEREDELİ ÇAĞLAYAN,KARAKURT ERYILMAZ MELEK,YILDIRIM MAHMUT SELMAN,AKKULOĞLU TUBA,İNAL ALİ,IŞIKDOĞAN ABDURRAHMAN,BOZCUK HAKAN,DEMİRKAZIK AHMET
Uluslararası
Hakemli
2020
18. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
Esin Ece,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,BİLİCİ AHMET,ÇİÇİN İRFAN,KÖSTEK OSMAN,KAPLAN MUHAMMET ALİ,AKSOY SERCAN,Özdemir O,Alacacioglu Ahmet,ÇABUK DEVRİM,SÜMBÜL AHMET TANER,Sakin A,PAYDAŞ SEMRA,Yetişir E,ER ÖZLEM,KORKMAZ TANER,Yıldırım N,Sakalar T,Demir H,ARTAÇ MEHMET,Müge Karaagaç,HARPUTLUOĞLU HAKAN,Bilen E,Erdur E,DEĞİRMENCİOĞLU SERKAN,Aliyev A,ÇİL TİMUÇİN,Olgun P,BAŞARAN GÜL,Gumusay O,TANRIKULU ŞİMŞEK EDA,YUMUK PERRAN FULDEN,İmamoğlu İnanç,OYAN ULUÇ BAŞAK,Çetin B,Haksöyler V,KARADURMUŞ NURİ,Ertürk I,EVRENSEL TÜRKKAN,Yılmaz H,Beypınar I,Koçer M,Pilanci K N,ÜRÜN YÜKSEL,Yıldırım N,Eren T,DEMİRCİ UMUT
Uluslararası
Hakemli
2019
19. Effects of Adjuvant Therapy on Body Composition Measurements in Women With Early Breast Cancer
KARAKURT ERYILMAZ MELEK,KARAAĞAÇ MUSTAFA,ARAZ MURAT,ATABEK MEHMET EMRE,ARTAÇ MEHMET
Ulusal
Hakemli
2019
20. A Lung Adenocarcinoma Patient With EGFR Mutation in Exon 18 and ALK-rearrangement WhoTreated With Erlotinib and Crizotinib
ARTAÇ MEHMET,KORKMAZ LEVENT,KARAAĞAÇ MUSTAFA,KAYA BUĞRA,POYRAZ NECDET,ÖZÖN HAKAN,ER ZEHRA,TAVLI LEMA
Uluslararası
Hakemli
2018
21. Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated With FOLFIRI-Bevacizumab
ARTAÇ MEHMET,UYSAL MÜKREMİN,KARAAĞAÇ MUSTAFA,KORKMAZ LEVENT,ER ZEHRA,GÜLER TUNÇ,BÖRÜBAN MELİH CEM,BOZCUK HAKAN
Uluslararası
Hakemli
2017
22. Survivin Expression May Affect The Neoadjuvant Chemotherapy Response in Breast Cancer Patients
DEMİRCİOĞLU SİNAN,ARTAÇ MEHMET,KORKMAZ LEVENT,Gündüz Şeyda,KARAAĞAÇ MUSTAFA,ESEN HACI HASAN,ERDOĞAN GÜLGÜN,Er Zehra,PEŞTERELİ HADİCE ELİF,TAVLI LEMA,Bozcuk Hakan
Uluslararası
Hakemli
2017
23. Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients
ARTAÇ MEHMET,KORKMAZ LEVENT,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KARAAĞAÇLI MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,doruk hatice,AVCI NİLÜFER,turhal serdar
Uluslararası
Hakemli
2019
24. Prognostic value of ERCC1 ERCC2 XRCC1 and TP53 single nucleotide polymorphisms in patients with early stage non small cell lung cancer
caglayan Geredeli,ARTAÇ MEHMET,YILDIRIM MAHMUT SELMAN,İnal Ali,İsa Dede,GÜLER TUNÇ,BÖRÜBAN MELİH CEM,KORAL LOKMAN,Karaağaç Mustafa,Zamani Ayşegül,Tamer Altunok,ARIBAŞ OLGUN KADİR,Hakan Bozcuk,DEMİRKAZIK AHMET
Uluslararası
Hakemli
2015
25. Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease
Geredeli Caglayan,Cihan Sener,Yasar Nurgul,SAKİN ABDULLAH,Can Orcun,ARTAÇ MEHMET,KARAAĞAÇ MUSTAFA,KORAL LOKMAN
Ulusal
Hakemli
2018
26. Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer
DEMİRCİOĞLU SİNAN,KORKMAZ LEVENT,YILMAZ SEDA,BEKTAŞ ÖZLEN,ÇENELİ ÖZCAN,ARTAÇ MEHMET
Uluslararası
Hakemli
2017
27. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.
AKBULUT HAKAN,Muge Ocal,Fatma Gizem Sonugur,Abdi Abgarmi Samira,Babahan Cansu,Akay Busra,Yalçintas Arslan Ülkü,ARTAÇ MEHMET,ŞENDUR MEHMET ALİ NAHİT,Ahmet Demirkazik
Uluslararası
Hakemli
2018
28. A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2 gastric or gastroesophageal junction cancer (TOXAG study).
ABALI HÜSEYİN,YALÇIN ŞUAYİB,ÖNAL HÜSEYİN CEM,DANE FAYSAL,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR NURİYE,MERTSOYLU HÜSEYİN,ARTAÇ MEHMET,camcı celalettin,KARABULUT BÜLENT,basa fatma,budakoğlu burçin,ŞENDUR MEHMET ALİ NAHİT,göktaş B,özdener A,Baygül A
Uluslararası
Hakemli
2018
29. The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors
ARTAÇ MEHMET,Bozcuk Hakan,Afacan Berna,ÖZDOĞAN MUSTAFA,Samur Mustafa
Uluslararası
Hakemli
2008
30. Prognostic Impact of Neutrophil Lymphocyte Ratio Platelet Count CRP and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Bevacizumab
ARTAÇ MEHMET,UYSAL MÜKREMİN,karaağaç mustafa,KORKMAZ LEVENT,ER ZEHRA,GÜLER TUNÇ,BÖRÜBAN MELİH CEM,BOZCUK HAKAN
Uluslararası
Hakemli
2016
31. Changes in lifestyle upon diagnosis of cancer or other chronic illnesses: A Turkish Oncology Group study
Turhal Nazım Serdal,akıncı figen,hacıabdullahoğlu yasemin,dolmacı makbule,sarı ayşe,gülhan nermin,mutlu aylin,ÖZDEMİR FEYYAZ,ARTAÇ MEHMET,KILIÇKAP SAADETTİN
Uluslararası
Hakemli
2018
32. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study
KORKMAZ LEVENT,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KARAAĞAÇLI MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,doruk hatice,AVCI NİLÜFER,turhal serdar,ARTAÇ MEHMET
Uluslararası
Hakemli
2018
33. The Evaluation of Relationship Between Malnutrition, Qality of Life and Depression in Cancer Patients Treated with Chemotherapy
ALKAN ŞENAY BURÇİN,ARTAÇ MEHMET,RAKICIOĞLU NESLİŞAH
Uluslararası
Hakemli
2018
34. A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALK-rearrangement who treated with erlotinib and crizotinib
ARTAÇ MEHMET,KORKMAZ LEVENT,KARAAĞAÇ MUSTAFA,KAYA BUĞRA,POYRAZ NECDET,ÖZÖN HAKAN,ER ZEHRA,TAVLI LEMA
Uluslararası
Hakemli
2018
35. The relationship between nutritional status and handgrip strength in adult cancer patients: a cross-sectional study
ALKAN ŞENAY BURÇİN,ARTAÇ MEHMET,RAKICIOĞLU NESLİŞAH
Uluslararası
Hakemli
2018
36. The prognostic significance of the18F‑fluorodeoxyglucose positron emissiontomography/computed tomography inearly‑stage nonsmall cell lung cancer
GEREDELİ ÇAĞLAYAN,ARTAÇ MEHMET,KOCAK İSMAİL,KORAL LOKMAN,SAKİN ABDULLAH,ALTINOK TAMER,KAYA BUĞRA,KARAAĞAÇ MUSTAFA
Uluslararası
Hakemli
2018
37. Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease
GEREDELİ ÇAĞLAYAN,Cihan Şener,YAŞAR Nurgül,SAKİN ABDULLAH,CAN ORÇUN,ARTAÇ MEHMET,KARAAĞAÇ MUSTAFA,KORAL LOKMAN
Ulusal
Hakemli
2018
38. Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)
ARTAÇ MEHMET,Bozcuk Hakan,KIYICI AYSEL,EREN ORHAN ÖNDER,BÖRÜBAN MELİH CEM,ÖZDOĞAN MUSTAFA
Uluslararası
Hakemli
2013
39. A prospectively validated nomogram for predicting the risk of chemotherapy induced febrile neutropenia a multicenter study
Hakan Bozcuk,Yıldız Mustafa,ARTAÇ MEHMET,KOÇER MURAT,Kaya Çetin,ULUKAL ECE,Kılıç Pelin,Ay Sevim,Handan Şimşek,Pelin Kılıçkaya,Selda Uçar,COŞKUN HASAN ŞENOL,Savaş Burhan
Uluslararası
Hakemli
2015
40. The acute effect of tropisetron on ECG parameters in cancer patients
Yavaş Özlem,YAZICI MEHMET,EREN ORHAN ÖNDER,BÖRÜBAN MELİH CEM,ARTAÇ MEHMET,GENÇ MİNE
Uluslararası
Hakemli
2008
41. Does maintenance consolidation chemotherapy have a role in the management of small cell lung cancer SCLC
Bozcuk Hakan,ARTAÇ MEHMET,Özdoğan Mustafa,Savaş Burhan
Uluslararası
Hakemli
2005
42. Do not tell what factors affect relatives attitudes to honest disclosure of diagnosis to cancer patients
Mustafa Özdogan,Samur Mustafa,Hakan Bozcuk,ÇOBAN ERKAN,ARTAÇ MEHMET,Savaş Burhan,Kara Arzu,Zekiye Topçu,Yeliz Sualp
Uluslararası
Hakemli
2004
43. Tumour necrosis factor alpha interleukin 6 and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy
Hakan Bozcuk,Gülcan Uslu,Samur Mustafa,Yıldız Mustafa,ÖZBEN TOMASİ TOMRİS,Özdoğan Mustafa,ARTAÇ MEHMET,Altınbaş Hasan,Ismail Akan,Savaş Burhan
Uluslararası
Hakemli
2004
44. An update on the multimodality of localized rectal cancer
ARTAÇ MEHMET,KORKMAZ LEVENT,Bassel F EL RAYES,PHİLİP PA
Uluslararası
Hakemli
2016
45. Asymptomatic Acute Pancreatitis Due to Tamoxifen Induced Severe Hypertriglyceridemia in a Patient with Diabetes Mellitus and Breast Cancer
ARTAÇ MEHMET,SARI RAMAZAN,ALTUNBAŞ HASAN ALİ,Karayalçın Ümit
Uluslararası
Hakemli
2002
46. Frequency of Cytochrome 450 CYP2C9 and CYP2C19 Genetic Polimorphismsin Patients with Colorectal Carcinoma
BÜYÜKDOĞAN MURAT,BÖRÜBAN MELİH CEM,ARTAÇ MEHMET
Ulusal
Hakemli
2008
47. CD19 deficiency A village screening study
REİSLİ İSMAİL,ARTAÇ HASİBE,PEKCAN SEVGİ,KELEŞ SEVGİ,ARTAÇ MEHMET
Ulusal
Hakemli
2009
48. Does music exposure during chemotherapy improve quality of life in earlybreast cancer patients A pilot study
Bozcuk Hakan,ARTAÇ MEHMET,Özdoğan Mustafa,Savaş Burhan
Uluslararası
Hakemli
2006
49. Cluster analysis of p glycoprotein c erb B2 and P53 in relation totumor histology strongly indicates prognosis in patients with operablenon small cell lung cancer
Samur Mustafa,Özdoğan Mustafa,Savaş Burhan,ARTAÇ MEHMET
Uluslararası
Hakemli
2004
50. Correlates of benefit from neoadjuvant chemotherapy before radiotherapyin non small cell lung cancer a meta analytical approach withmeta regression analysis
Bozcuk Hakan,Özdoğan Mustafa,ARTAÇ MEHMET
Uluslararası
Hakemli
2010
51. Severe pulmonary haemorrhage accompanying hepatorenal failure in fulminant leptospirosis
DURSUN BELDA,Bostan Fevzi,ARTAÇ MEHMET,Varan Halil İbrahim,SÜLEYMANLAR GÜLTEKİN
Uluslararası
Hakemli
2007
52. The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan based regimens
ARTAÇ MEHMET,Hakan Bozcuk,PEHLİVAN SACİDE,Songül Akcan,PEHLİVAN MUSTAFA,Tuğce Sever,Özdoğan Mustafa,Savaş Burhan
Uluslararası
Hakemli
2010
53. Changes in lifestyle upon diagnosis of cancer or other chronic illnesses A Turkish Oncology Group study
TURHAL NS,AKINCI F,ABDULLAHOĞLU HACI Y,DOLMACI M,SARI A,GÜRHAN N,MUTLU A,ÖZDEMİR F,ARTAÇ MEHMET
Uluslararası
Hakemli
2016
54. Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma A Turkish Oncology Group TOG Study
ARTAÇ MEHMET,COŞKUN HASAN ŞENOL,KORKMAZ LEVENT,KOÇER MURAT,TURHAL NS,ENGİN H,DEDE İ,PAYDAŞ S,BOZCUK HAKAN,DEMİRKAZIK AHMET
Uluslararası
Hakemli
2016
55. Benefit of Bevacizumab Based Frontline Therapy in Patients with Metastatic Colorectal Cancer mCRC a Turkish Oncology Group Study
ARTAÇ MEHMET,COŞKUN HASAN ŞENOL,KARABULUT BÜLENT,KORKMAZ LEVENT,KARAAĞAÇ MUSTAFA,ÇABUK D,KARABULUT S,AYKAN NURİ FARUK,DORUK HATİCE,AVCI N,TURHAL NS
Uluslararası
Hakemli
2016
56. Erlotinib Response in non small cell lung cancer patient with EGFR Exon 20 Mutation
KORKMAZ LEVENT,ARTAÇ MEHMET,KARAAĞAÇ MUSTAFA,ER ZEHRA,BÖRÜBAN MELİH CEM,POYRAZ NECDET,KAYA BUĞRA,TAVLI LEMA,ÖDEV KEMAL
Uluslararası
Hakemli
2016
57. Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer
Müsri FY,MUTLU HASAN,Karaağaç Mustafa,ERYILMAZ MK,GÜNDÜZ Ş,ARTAÇ MEHMET
Uluslararası
Hakemli
2016
58. Factors predicting lapatinib efficacy in HER 2 metastatic breast carcinoma Does it work better in different histologic subtypes
SEZGİN GÖKSU SEMA,KORAL LOKMAN,UYSAL MÜKREMİN,KOÇER MURAT,KARABULUT BÜLENT,COŞKUN HASAN ŞENOL,BOZCUK HAKAN,ÖZDOĞAN MUSTAFA,SAVAŞ BURHAN,ARTAÇ MEHMET,GÜNDÜZ ŞEYDA,TATLI MURAT,ARSLAN DENİZ,ÇAKAR BÜLENT
Uluslararası
Hakemli
2015
59. Trastuzumab based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer an Anatolian Society of Medical Oncology Study
Dogan Uncu,İbrahim Vedat Bayoglu,Ülkü Yalcıntaş,KÜÇÜKÖNER MEHMET,ARTAÇ MEHMET,Dogan Koca,OĞUZ ARZU,Umut Demirci,ARPACI ERKAN,Doğan Mutlu,KÜÇÜKZEYBEK YÜKSEL,Türker İbrahim,IŞIKDOĞAN ABDURRAHMAN,GÜLER TUNÇ,ZENGİN NURULLAH
Uluslararası
Hakemli
2015
60. Prevalence of K Ras mutations in hepatocellular carcinoma A A Turkish Oncology Group pilot study
Turhal Serdar,SAVAŞ BERNA,Öznur Çoşkun,Baş Emine,KARABULUT BÜLENT,NART DENİZ,KORKMAZ TANER,Dilek Yavuzer,DEMİR OSMAN GÖKHAN,Gülen Doğusoy,ARTAÇ MEHMET
Uluslararası
Hakemli
2015
61. Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma
Çağlayan Geredeli,BÖRÜBAN MELİH CEM,POYRAZ NECDET,ARTAÇ MEHMET,ARIBAŞ ALPAY,KORAL LOKMAN
Uluslararası
Hakemli
2015
62. Epidemiology of colorectal cancer in Turkey A cross sectional disease registry study A Turkish Oncology Group trial
AYKAN NURİ FARUK,YALÇIN ŞUAYİB,Turhal Serdar,Özdoğan Mustafa,DEMİR OSMAN GÖKHAN,ÖZKAN METİN,YAREN ARZU,Celalettin Camcı,AKBULUT HAKAN,ARTAÇ MEHMET,MEYDAN NEZİH,UYGUN KAZIM,IŞIKDOĞAN ABDURRAHMAN,Ünsal Diclehan,ÖZYILKAN ÖZGÜR,Arıcan Ali,Ertuğrul Seyrek,TEKİN SALİM BAŞOL,MANAVOĞLU OSMAN,ÖZET AHMET,ELKIRAN EMİN TAMER,Rian Dişci
Uluslararası
Hakemli
2015
63. Radiotherapy induced Hypopituitarism in Nasopharyngeal Carcinoma the Tip of an Iceberg
İPEKÇİ SÜLEYMAN HİLMİ,KIYICI AYSEL,KOÇ OSMAN,Çakır Mehtap,ARTAÇ MEHMET
Uluslararası
Hakemli
2015
64. Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer
MUTLU HASAN,YALÇIN MÜSRİ FATMA,ARTAÇ MEHMET,Ayşegül Kargı,Özdoğan Mustafa,Hakan Bozcuk
Uluslararası
Hakemli
2015
65. Do high risk features support the use of adjuvant chemotherapy in stage II colon cancer A Turkish Oncology Group study
ARTAÇ MEHMET,Serdar Turhal,KOÇER MURAT,KARABULUT BÜLENT,Hakan Bozcuk,YALÇIN ŞUAYİB,Karaağaç Mustafa,Gündüz Şeyda,Işık Nalan,UYGUN KAZIM
Uluslararası
Hakemli
2014
66. Different clinical features of primary and secondary tumor s in patientswith multiple malignancies
ARTAÇ MEHMET,Hakan Bozcuk,Özdoğan Mustafa,DEMİRAL AYŞE NUR,Alper Sarper,Samur Mustafa,Savaş Burhan
Uluslararası
Hakemli
2005
67. Hemodialysis shortens long in vitro closure times as measured by the PFA 100
UĞUR BİLGİN AYNUR,İhsan Karadoğan,ARTAÇ MEHMET,Aytuğ Kızılörs,Rasim Bilgin,ÜNDAR LEVENT
Uluslararası
Hakemli
2007
68. An Atypical Case of POEMS Syndrome with IgG Kappa M Protein and End Stage Renal Failure
DURSUN BELDA,ARTAÇ MEHMET,Halil İbrahim Varan,AKKAYA BAHAR,Gülten Karpuzoğlu,SÜLEYMANLAR GÜLTEKİN
Uluslararası
Hakemli
2005
69. Gene methylation of SFRP2 P16 DAPK1 HIC1 and MGMT and KRAS mutations in sporadic colorectal cancer
PEHLİVAN SACİDE,ARTAÇ MEHMET,Tugce Sever,Hakan Bozcuk,Can Kılınçaslan,PEHLİVAN MUSTAFA
Uluslararası
Hakemli
2010
70. Leptin and breast cancer an overview
ARTAÇ MEHMET,ALTUNDAĞ MUSTAFA KADRİ
Uluslararası
Hakemli
2012
71. Demographics Clinical Presentations and Outcomes ofCancer Patients Admitted to the Emergency Department
BOZDEMİR MEHMET NURİ,ERAY OKTAY,EKEN CENKER,Yesim Senol,ARTAÇ MEHMET,Samur Mustafa
Uluslararası
Hakemli
2009
72. Factors Related to Truth Telling Practice of Physicians Treating Patients with Cancer in Turkey
Özdoğan Mustafa,Samur Mustafa,ARTAÇ MEHMET,Yıldız Mustafa,Savaş Burhan,Hakan Bozcuk
Uluslararası
Hakemli
2006
73. A simple and accurate prediction model to estimate the intrahospitalmortality risk of hospitalised cancer patients
Hakan Bozcuk,Koyuncu Emine,Yıldız Mustafa,Samur Mustafa,Özdoğan Mustafa,ARTAÇ MEHMET,ÇOBAN ERKAN,Savaş Burhan
Uluslararası
Hakemli
2004
74. Realities and expectations of pharmacogenomics and personalized medicine impact of translating genetic knowledge into clinical practice
Al Squassina,Mu Manchia,Vangelis Monolopoulos,ARTAÇ MEHMET,cris Lappa,Sofi Karkabouna,Ka Mitropoulos,Ma Del Zompo,George Patrinos
Uluslararası
Hakemli
2010
75. Complete response and long term remission to anti HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases
ARTAÇ MEHMET,BÖRÜBAN MELİH CEM,ALTUNDAĞ MUSTAFA KADRİ
Uluslararası
Hakemli
2014
76. Efficacy and Safety of Erlotinib in Previously Treated Advanced Non Small Cell Lung Cancer
KARACA HALİT,ALICI SÜLEYMAN,ARTAÇ MEHMET,ÖZKAN METİN,IŞIKDOĞAN ABDURRAHMAN,BENEKLİ MUSTAFA,BERK VELİ
Uluslararası
Hakemli
2013
77. Brucellosis in febrile neutropenia
Artac Mehmet, Sari Ramazan
Uluslararası
Hakemli
2007
78. The Debate About Maintenance Is Not Over in Small Cell Lung Cancer
Artac M., Bozcuk H.
Uluslararası
Hakemli
2007
79. Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein 1 dependent way An in vitro study
Yildiz Mustafa, Celik-Ozenci Ciler, Akan Selma, Akan Ilhan, Sati Leyla, Demir Ramazan, Savas Burhan, Ozben Tomris, Samur Mustafa, Ozdogan Mustafa
Uluslararası
Hakemli
2006
80. Quality of Life in Patients With Advanced Non Small Cell Lung Cancer
Bozcuk Hakan, Dalmis Berna, Samur Mustafa, Ozdogan Mustafa, Artac Mehmet, Savas Burhan
Uluslararası
Hakemli
2006
81. Durable Remission of Leptomeningeal Metastasis of Breast Cancer with Letrozole a Case Report and Implications of Biomarkers on Treatment Selection
Ozdogan M.
Uluslararası
Hakemli
2003
82. Chemotherapy induced Hepatitis B virus reactivation in HbsAg positive cancer patients a single center experience
Eren Orhan Onder, Artac Mehmet, Boruban Melih Cem, Yavas Ozlem, Arslan Ugur, Basaranoglu Metin
Uluslararası
Hakemli
2009